News

December 14, 2018December 14, 2018

Aridis Enrolling CF Patients to Test AR-501 in Chronic Lung Infections

cystic fibrosis, News

Aridis Pharmaceuticals has enrolled the first healthy participant in its Phase 1/2a clinical trial to evaluate the antibacterial potential of its investigational candidate, AR-501 (gallium citrate), against chronic lung ... Read more

December 13, 2018December 13, 2018

Specific Sweat Test Better Detects Kalydeco’s Effects on CFTR Function, Study Suggests

cystic fibrosis, News

The effects of CFTR modulator therapies such as Kalydeco (ivacaftor) can be more reliably assessed using a test that specifically measures the sweating dependent on CFTR, called C-sweat rate, than using ... Read more

December 12, 2018December 12, 2018

Young CF Patients Deem Wrist-worn Devices Acceptable for Monitoring Physical Activity, Study Finds

cystic fibrosis, News

Wrist-worn monitoring devices are an acceptable method of objectively tracking the levels of physical activity of children and young people with cystic fibrosis (CF), a study reports. The study, “A ... Read more

December 11, 2018December 11, 2018

Higher Interleukin-7 Serum Levels Could be Biomarker for CF, Study Suggests

cystic fibrosis, News

A recent study confirmed the presence of increased serum levels of interleukin-7 (IL-7) in cystic fibrosis (CF) patients, compared with healthy controls. The researchers could establish a link between ... Read more

December 10, 2018December 10, 2018

Handheld Wireless Home Spirometer Could Transform CF Monitoring, Pilot Study Suggests

cystic fibrosis, News

Air Next, a small, simple-to-use handheld spirometer, could transform cystic fibrosis (CF) treatment, allowing patients to monitor their own lung function at home and share the results remotely with their healthcare ... Read more

December 7, 2018December 7, 2018

Aridis to Start Phase 1/2a Trial for Inhalable Antibacterial Therapy AR-501 in CF Patients

cystic fibrosis, News

Aridis Pharmaceuticals is planning to launch a Phase 1/2a clinical trial in the beginning of 2019 to evaluate the potential of its investigational antibacterial compound AR-501 (gallium citrate) in ... Read more

December 6, 2018December 6, 2018

Inhaled Hypertonic Saline Improves Lung Health in Preschoolers with CF, Study Shows

cystic fibrosis, News

Preschoolers with cystic fibrosis (CF) treated with inhaled hypertonic saline in a clinical trial showed significant improvement in lung function, PARI, the company whose solution and equipment was used in the ... Read more

December 5, 2018December 5, 2018

CF Patients Benefit from Virtual Learning, New Educational Programs

cystic fibrosis, News

It’s one of the ironies of cystic fibrosis (CF) conferences that the patients who most urgently need the information are discouraged from attending for fear of cross-contamination. Under infection ... Read more

December 4, 2018December 4, 2018

Mastercard Executives Lead the Way in Growing Relationship with CF Foundation

cystic fibrosis, News

For the second year in a row, Mastercard ranks as the largest corporate sponsor of the Greater New York chapter of the Cystic Fibrosis Foundation (CFF). This year alone, Mastercard ... Read more

December 3, 2018December 3, 2018

Researchers Working on Vaccine Against P. aeruginosa Before Infection Sets In

cystic fibrosis, News

Researchers at West Virginia University (WVU) are working to develop a vaccine against Pseudomonas aeruginosa, the highly treatment-resistant bacteria that are a frequent cause of chronic lung infection and damage in cystic fibrosis ... Read more

Pin It on Pinterest